GB2198436A - Isomerisation of 1.2.4-triazoles - Google Patents

Isomerisation of 1.2.4-triazoles Download PDF

Info

Publication number
GB2198436A
GB2198436A GB08726876A GB8726876A GB2198436A GB 2198436 A GB2198436 A GB 2198436A GB 08726876 A GB08726876 A GB 08726876A GB 8726876 A GB8726876 A GB 8726876A GB 2198436 A GB2198436 A GB 2198436A
Authority
GB
United Kingdom
Prior art keywords
triazole
alkyl
substituted
isomerisation
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08726876A
Other versions
GB8726876D0 (en
Inventor
Michael Gordon Hutchings
Andrew Small
Keith Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629052A external-priority patent/GB8629052D0/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB08726876A priority Critical patent/GB2198436A/en
Publication of GB8726876D0 publication Critical patent/GB8726876D0/en
Publication of GB2198436A publication Critical patent/GB2198436A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Heating a 4H-substituted-1,2-4-triazole of the formula: <IMAGE> wherein R is a monovalent organic radical, at a temperature above 100 DEG C, in the presence of a compound R-X, wherein X is a leaving group, causes the compound of Formula I to be transformed into the isomeric 1H-substituted-1,2,4-triazole.

Description

Isomerisation Process This specification describes an invention relating to an isomerisation process and more particularly one for converting a 4H-substituted-1,2,4-triazole into the isomeric 1H-substituted1,2,4-triazole.
According to the present invention there is provided a process which comprises heating a 4H-substituted-1,2,4-triazole of the formula:
wherein R is a monovalent organic radical, at a temperature above 1000C, in the presence of a compound R-X, wherein X is a leaving group, whereby the compound of Formula I is transformed into the isomeric 1H-substituted-1 , 2, 4-triazole.
The monovalent organic radical, R, may be any organic radical which is stable under the conditions of the isomerisation reaction. Classes of suitable organic radical are: (a) Aliphatic groups, such as alkyl, cycloalkyl and cycloalkylalkyl, preferably C120-alkyl, and more especially C alkyl; C3 8-cycloalkyl and C3 8-cycloalkyl-Cl~4-alkyl e.g. methyl, ethyl, pentyl, 2-ethylhexyl, octadecyl, cyclohexyl, 1-(cyclo propyl)ethyl, cyclohexylethyl and cyclohexylmethyl.
(b) Arylaliphatic groups, such as arylalkyl, especially phenyl- and substituted-phenyl-Cl 4-alkyl, e.g. benzyl, 2-phenylethyl, 2-(4-chlorophenyl)ethyl.
(c) Aryl groups, especially optionally substituted phenyl or naphthyl, e.g. phenyl, 4-chlorophenyl, 4-nitrophenyl, 4-hydroxyphenyl, l-napthyl and 2-naphthyl.
(d) Hydrocarbylcarbonylalkyl groups of the formula:
R1 and R2 in which R and R are each independently optionally sub stituted hydrocarbyl (where hydrocarbyl includes cycloalkyl, alkyl, cycloalkylalkyl, aralkyl, aryl, preferably of the type defined in (a), (b) and (c) above, and optional substituents include halogen, alkyl, haloalkyl and alkoxy, especially those in which the alkyl contains up to 4 carbon atoms); R1 is optionally substituted hydrocarbyl as hereinbefore defined and R is H; or R1 and R2 are linked to form an aliphatic ring, especially a cycloalkanone containing from 4 to 8 carbon atoms, which groups and combinations of groups are described in GB 1,464,224 and GB 1,595,696.Specific examples of alkyl- and aryl-carbonylalkyl groups are: acetylmethyl, (t-butyryl)-methyl, 1-(t-butyryl)-ethyl, 1-(t-butyryl)-2-(4-chlorophenyl)-ethyl, I-(t-butyryl)-2-(2,4-dichlorophenyl)-ethyl, and arylcarbonylmethyl groups, such as 4-fluorophenacyl, 4-chlorophenacyl, 4-cyano-2-fluorophenacyl, 4-bromophenacyl, 2,4-dichlorophenacyl, 2,4-difluorophenacyl and phenacyl.
(e) Secondary alcohols derived by reduction of the hydrocarbyl carbonylalkyl groups described in (d) above, such as 1- (4-chlorobenzyl)-2-hydroxy-2-t-butyl-ethyl and 1-(2,4-dichlorobenzyl)-2-*lydroxy-2-t-butyl-ethyl (f) Heterocyclic groups, both aromatic and alicyclic, especially 5 and 6 membered mono- and bi-heterocyclic groups, e.g. pyridyl, piperidino, morpholino, piperazino, furyl, thienyl.
The monovalent radical R may be substituted by groups which are inert under the isomerisation reaction conditions. Suitable substitutents include halogen, especially fluorine, chlorine and bromine; alkyl, haloalkyl, alkenyl and alkoxy, especially those containing up to 4 carbon atoms; nitro; cyano; phenyl; hydroxy; amino; acyl, such as alkyl- and aryl-carbonyl and sulphonyl, carbamoyl, such as unsubstituted and mono- and di- alkyl- & BR< aryl-aminocarbonyl; acylamino, such as alkyl- and aryl-carbonylamino; and acyloxy such as aryl- and alkyl-carbonyloxy.
Preferred radicals represented by R are benzyl, phenacyl, 4-chlorophenacyl, 4-fluorophenacyl, 4-bromophenacyl, 2,4-dichlorophenacyl, 2,4-difluorophenacyl, 4-cyano-2-fluorophenacyl, 3-(4-chlorophenyl)-acetonyl, l-(t-butyryl)-2-(4-chlorophenyl)-ethyl, 1-(t-butyryl) -2-(2,4-dichlorophenyl) -ethyl.
The identity of the leaving group, X, is not critical but preferred leaving groups include halogen, especially chlorine or bromine; aryl- and alkyl-sulphonates and carboxylates and derivatives thereof, such as tosylate, mesylate, acetate, trifluoroacetate.
Only catalytic quantities of the compound R-X are required to effect the isomerisation though larger quantities are not generally detrimental. However, for technical and economic reasons it is preferred to use from about 1 - 15 %mole and more especially from 2 - 7 %mole, of R-X.
The isomerisation is preferably performed at a temperature above 1200C especially above 150 C. Preferred temperature ranges are from 1200C to 2000C, and especially from 1500C to 1800C. The precise temperature employed will, however, depend upon the stability of the radical, R, the nature of X, the presence or absence of a reaction medium, the period on temperature and the energy barrier to be overcome in the isomerisation.
The compound of Formula I and the catalyst may be heated alone or suspended or dissolved in a suitable reaction medium, such as an organic liquid. Suitable organic liquids are preferably those with a boiling point in the range 1200C to 2000C or above and more especially at or above 1500C. Examples of suitable solvents are N-methylpyrrolidone, dimethylformamide, formamide, dimethylaniline, ureas, dimethylsulphoxide, nitrobenzene, halobenzenes, 1,3-dimethyl2-imidazolinone, glycols, polyglycols, glycol ethers and esters.
The isomerisation may be performed in the presence of the isomeric 1H-substituted-1,2,4-triazole, which generally being more thermodynamically stable than the 4H-substituted-1,2,4-triazole remains unchanged in the reaction mixture. Thus, the process is of especial value in converting the relatively minor proportion, generally around 15% or below, of the less desirable 4H-substituted1,2,4-triazole (which is formed during the preparation of a 1H-substituted-1,2,4-triazole by reaction between a 1,2,4-triazole and the compound R-X or the epoxide derivative thereof) into the more desirable 1H-substituted-1,2,4-triazole.
A specific example of the present invention is the conversion of 4H-benzyl-1,2,4-triazole into 1H-benzyl-1,2,4-triazole by heating the former at 1800C for 21 < hours in the presence of 3% mole of benzyl chloride. Another example is the conversion of 4H-(phenacyl)-1,2,4-triazole into 1H-(phenacyl)-1,2,4-triazole by heating the former at 160-180"C for 6 hours in the absence of solvent, or at 1500C for 36 hours in N-methylpyrrolidone, in the presence of 13 or 10% mole, respectively, of alpha-chloroacetophenone.
The invention is further illustrated by the following Examples in which all percentages are by weight unless otherwise indicated.
Example 1 Conversion of 4H-benzyl-1,2,4-triazole into lH-benzyl-1 ,2,4-triazole 4H-Benzyl-1,2,4-triazole (0.2g, 1.26mmol) was placed in a 5 ml round bottomed flask fitted with a reflux condenser and drying tube. Benzyl bromide (7.2mg, 4.2x10 5mole, 3.3 mole%) was added and the mixture heated to 1800C for 21 < hours before being analysed by 'H nmr spectroscopy. More than 90% of the starting material had been converted to lH-benzyl-1,2,4-triazole.
Example 2 4H-Phenacyl-1,2,4-triazole (0.1359g, 0.73mmoles) and alphachloroacetophenone (0.0154g, 0.096 mmoles, 13.6 %mole) were placed in a 5 ml round bottomed flask. Methanol (5 ml) was added to dissolve both compounds and then removed in vacuo to produce a white solid evenly covered in alpha-chloroacetophenone. The solid was heated at 1600C for 1 hour and then at 1800C until complete conversion had taken place. The relative proportions of lH-phenacyl-1,2,4-triazole (1,2,4-isomer) and 4H-phenacyl-1,2,4-triazole (1,3,4-isomer) were determined by HPLC at regular intervals and the results are shown in the following table.
Temperature & Isomer Ratio Period on Temperature 1,2,4-isomer: 1,3,4-isomer 1600C 1 hour + 1800C 1 hour 44 : 56 1600C 1 hour + 1800C 2 hours 61 : 39 1600C 1 hour + 1800C 4 hours 92 : 8 1600C 1 hour + 1800C 6 hours 100 : 0

Claims (1)

  1. CLAIM A process which comprises heating a 4H-substituted1,2-4-triazole of the formula:
    wherein R is a monovalent organic radical, at a temperature above 100"C, in the presence of a compound R-X, wherein X is a leaving group, whereby the compound of Formula I is transformed into the isomeric 1H-substituted-1,2,4-triazole.
GB08726876A 1986-12-04 1987-11-17 Isomerisation of 1.2.4-triazoles Withdrawn GB2198436A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08726876A GB2198436A (en) 1986-12-04 1987-11-17 Isomerisation of 1.2.4-triazoles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629052A GB8629052D0 (en) 1986-12-04 1986-12-04 Isomerisation process
GB08726876A GB2198436A (en) 1986-12-04 1987-11-17 Isomerisation of 1.2.4-triazoles

Publications (2)

Publication Number Publication Date
GB8726876D0 GB8726876D0 (en) 1987-12-23
GB2198436A true GB2198436A (en) 1988-06-15

Family

ID=26291646

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08726876A Withdrawn GB2198436A (en) 1986-12-04 1987-11-17 Isomerisation of 1.2.4-triazoles

Country Status (1)

Country Link
GB (1) GB2198436A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102321035A (en) * 2011-06-14 2012-01-18 江苏七洲绿色化工股份有限公司 Method for removing 1,3,4-triazole substitute material from 1,2,4-triazole substitute material

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102321035A (en) * 2011-06-14 2012-01-18 江苏七洲绿色化工股份有限公司 Method for removing 1,3,4-triazole substitute material from 1,2,4-triazole substitute material
CN102321035B (en) * 2011-06-14 2013-07-03 江苏七洲绿色化工股份有限公司 Method for removing 1,3,4-triazole substitute material from 1,2,4-triazole substitute material

Also Published As

Publication number Publication date
GB8726876D0 (en) 1987-12-23

Similar Documents

Publication Publication Date Title
KR950008512A (en) Method for preparing imidazopyridine derivative
US3133916A (en) -ch chj
US5101028A (en) (1,2,4)triazolo[2,3-a]pyridines
US3470167A (en) Triazolyl styryl optical whitening agents
US5182389A (en) Process for the preparation of 2-(2&#39;,4&#39;-dihydroxyphenyl)-4,6-diaryl-s-triazines
US4064136A (en) Process for the manufacture of benzoxazole, benzthiazole and benzimidazole derivatives
GB2198436A (en) Isomerisation of 1.2.4-triazoles
US4248775A (en) Preparation of solutions of azo methine basic dyestuffs
DE2000027A1 (en) Optical brighteners
DE2710285A1 (en) PROCESS FOR THE MANUFACTURING OF CUMARIN DYES
US4125717A (en) Process for the preparation of oxazine dyestuffs
JPH01216976A (en) Production of 1-hydroxyalkyl-5-nitroimidazole
O'Callaghan et al. Anticancer Agents XIII. Synthesis and antitumour activity of 2-iminochromene derivatives
US2527494A (en) Process for preparation of orthoformic esters
DE2856873A1 (en) ORGANIC COMPOUNDS, THEIR PRODUCTION AND USE
US3956311A (en) Process for the preparation of 3-anilino-pyrazolones-(5)
US2940983A (en) Halogen substituted dinaphthofurandiones
US4271293A (en) Benzofuranyl-benzimidazoles
US4401600A (en) Certain 3-phenylhydrazono-2-amino-1,1,3-propene tricarbonitrile
US3869469A (en) 7-triazolyl-3-aryl coumarin compounds
US4240963A (en) Preparation of indolenines
EP0021304A1 (en) Coumarin compounds, their preparation and their use as dyestuffs
US3925405A (en) Triazole-coumarins
US3879417A (en) 3-4-(Pyrazole-1-yl)-3-halophenyl-7-alkoxy coumarin derivatives
US4046771A (en) Styryl dyestuffs

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)